Desq Long
Sign in
SEC FORM 4
$9,713.41

Lexeo Therapeutics, Inc. (LXEO)

Acquisition (code A) of 2,714 shares at $3.579 per share.

Reporting Person Bhalla Narinder Pal · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 14, 2026 · Disclosed Sep 28, 2026FILED +14 DAYS

Source: SEC Form 4 · 0002109299-26-000009 · filed 2026-09-28 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Lexeo Therapeutics, Inc. (LXEO)." Disclosed 2026-09-28. https://desqlong.com/cards/0002109299-26-000009-1 (retrieved 2026-09-29).